{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T18:47:09Z","timestamp":1763837229145,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007292","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bioorg.2020.103595","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:50:14Z","timestamp":1579693814000},"page":"103595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase"],"prefix":"10.1016","volume":"96","author":[{"given":"Yali","family":"Sang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fener","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103595_b0005","unstructured":"UNAIDS (last accessed January 8, 2020), https:\/\/www.unaids.org\/en\/resources\/documents\/2019\/2019-UNAIDS-data."},{"key":"10.1016\/j.bioorg.2020.103595_b0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/jm501132s","article-title":"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities","volume":"58","author":"Vernekar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0015","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1021\/jm040072r","article-title":"Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties","volume":"47","author":"Freeman","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0020","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.jmedchem.8b01656","article-title":"Identification of Dihydrofuro[3,4-d]pyrimidine Derivatives as Novel HIV-1 non-nucleoside reverse transcriptase inhibitors with promising antiviral activities and desirable physicochemical properties","volume":"62","author":"Kang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4155\/fmc.14.50","article-title":"Conformational restriction: an effective tactic in 'follow-on'-based drug discovery","volume":"6","author":"Fang","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0030","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/med.20241","article-title":"HIV-1 NNRTIs: structural diversity, pharmacophore similarity, and implications for drug design","volume":"33","author":"Zhan","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2020.103595_b0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1573409915666181219125944","article-title":"Comparative docking studies: a drug design tool for some pyrazine- thiazolidinone based derivatives for anti-HIV activity","volume":"15","author":"Asgaonkar","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.bioorg.2020.103595_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.10.029","article-title":"Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques","volume":"161","author":"Costa","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1021\/acs.jmedchem.8b01729","volume":"62","author":"Huang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0050","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1021\/ja034308c","article-title":"Validation of a model for the complex of HIV-1 reverse transcriptase with nonnucleoside inhibitor TMC125","volume":"125","author":"Udier-Blagovic","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.103595_b0055","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/acs.biochem.6b00113","article-title":"Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 reverse transcriptase: a fluorine nuclear magnetic resonance study","volume":"55","author":"Sharaf","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2020.103595_b0060","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1021\/jm900854h","article-title":"Conformational landscape of the human immunodeficiency virus type 1 reverse transcriptase non-nucleoside inhibitor binding pocket: lessons for inhibitor design from a cluster analysis of many crystal structures","volume":"52","author":"Paris","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0065","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1021\/acs.jmedchem.8b00843","article-title":"The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic","volume":"62","author":"Namasivayam","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2017","key":"10.1016\/j.bioorg.2020.103595_b0070","first-page":"132","article-title":"Update of the drug resistance mutations in HIV-1","volume":"24","author":"Wensing","year":"2017","journal-title":"Top. Antivir. Med."},{"key":"10.1016\/j.bioorg.2020.103595_b0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0006-291X(89)92756-3","article-title":"Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative","volume":"165","author":"Baba","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.103595_b0080","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/343470a0","article-title":"Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives","volume":"343","author":"Pauwels","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.103595_b0085","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1021\/acs.jmedchem.9b00175","article-title":"Fifty years in search of selective antiviral drugs","volume":"62","author":"De Clercq","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0090","article-title":"Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years","author":"Zhuang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2020.103595_b0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/acsmedchemlett.8b00549","article-title":"Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors","volume":"10","author":"Pribut","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103595_b0100","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.9b01446","article-title":"Ligand-based design of nondimethylphenyl-diarylpyrimidines with improved metabolic stability, safety and oral pharmacokinetic profiles","author":"Sang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0105","article-title":"Molecular hybridization-inspired optimization of diarylbenzopyrimidines as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved activity against K103N and E138K mutants and pharmacokinetic profiles","author":"Han","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2020.103595_b0110","doi-asserted-by":"crossref","first-page":"111603","DOI":"10.1016\/j.ejmech.2019.111603","article-title":"Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"182","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0115","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1021\/jm500045x","article-title":"Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates","volume":"57","author":"Kawamura","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0120","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1021\/jm501940y","article-title":"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead","volume":"58","author":"Orbe","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0125","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1021\/jm2014875","article-title":"Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections","volume":"55","author":"Montgomery","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0130","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1021\/jm049082i","article-title":"2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors","volume":"48","author":"Allegretti","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0135","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(06)69155-1","article-title":"The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial","volume":"368","author":"Eron","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2020.103595_b0140","doi-asserted-by":"crossref","first-page":"9722","DOI":"10.1021\/acs.jmedchem.8b01227","article-title":"Design and Synthesis of Potent HIV-1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure-Activity Studies and Biological and X-ray Structural Studies","volume":"61","author":"Ghosh","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejmech.2015.08.007","article-title":"Pyrimidine sulfonylacetanilides with improved potency against key mutant viruses of HIV-1 by specific targeting of a highly conserved residue","volume":"102","author":"Wan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0150","article-title":"Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors","author":"Han","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0155","article-title":"Fragment-based discovery of sulfur-containing diarylbenzopyrimidines as novel nonnucleoside reverse transcriptase inhibitors","author":"Han","year":"2019","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103595_b0160","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejmech.2018.01.016","article-title":"Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1","volume":"145","author":"Jin","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0165","doi-asserted-by":"crossref","first-page":"102974","DOI":"10.1016\/j.bioorg.2019.102974","article-title":"Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strains","volume":"89","author":"Sang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0170","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1021\/acs.joc.6b03058","article-title":"Synthesis of Alkylated Pyrimidines via Photoinduced Coupling Using Benzophenone as a Mediator","volume":"82","author":"Kamijo","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2020.103595_b0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nprot.2007.517","article-title":"Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later","volume":"3","author":"Pannecouque","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2020.103595_b0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0026-895X(24)12873-8","article-title":"Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance\/sensitivity to non-nucleoside reverse transcriptase inhibitors","volume":"61","author":"Auwerx","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103595_b0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abio.1997.2177","article-title":"Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation","volume":"249","author":"Singer","year":"1997","journal-title":"Anal. Biochem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819320541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819320541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:57:43Z","timestamp":1758614263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819320541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":37,"alternative-id":["S0045206819320541"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103595","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103595"}}